Co-Diagnostics, a molecular diagnostics company, emphasized that its Co-Dx PCR Pro platform could be adapted for plague diagnostics following a reported death of a lab worker in Russia suspected of pneumonic plague. While no plague has been confirmed by authorities, the company points to its experience with COVID-19, mpox, and Ebola to underline its readiness to develop rapid tests if needed. Their technology, including sputum sample preparation used in tuberculosis testing, provides a foundation for quick response to emerging infectious diseases. Currently, no plague-specific test development has started, but Co-Diagnostics is monitoring the situation closely and is prepared to act if necessary.
Co-Diagnostics and its PCR platform capabilities provide context for health diagnostics innovation. For readers following health-sector stocks, here is Pluang's market snapshot as of Oct 15, 2026 19:31 WIB: Out of 150 priced US health-sector stocks tradable on Pluang, 95 rose and 46 fell today. Notable movers include ASND at USD 219.09 with a 1-day change of -3.48% and 100% sell order activity, FLNA at USD 0.71 down 3.23% with a near-even buy-sell split, and AZN at USD 167.07 up 3.11% with 59% buy order activity and a typical hold time of 126 days.
TiDB, powered by PingCAP, announced new cloud platform capabilities to support enterprise and AI applications on a unified data foundation. Key updates include the upcoming general availability of TiDB Cloud Premium, public previews of Bring Your Own...
The Saudi Arabia Non-Invasive Prenatal Testing (NIPT) market is projected to grow from $52.5 million in 2025 to $162.16 million by 2034, at a CAGR of 13.35%. Growth is fueled by rising maternal age, advances in molecular diagnostics, and increased he...
ONEOK completed a $4.425 billion acquisition of Brazos Midstream's natural gas assets, doubling its processing capacity in the Permian Midland Basin to about 2.3 billion cubic feet per day. The deal secures 600,000 acres under long-term contracts, st...
Charles Schwab reported Q3 earnings per share of $1.69, beating estimates despite slightly missing revenue forecasts with $7.17 billion. The quarter marked a 17% revenue increase year-over-year and a 23% rise in net income to $2.91 billion, driven by...
Alcoa will release its Q3 2026 earnings on October 15, with analysts divided on earnings per share and revenue forecasts due to factors like rising aluminum sales, inventory changes, and higher input costs. The company expects a 54.9% jump in aluminu...
